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INTRODUCTION
It is estimated that approximately 40% 
of all cases of cancer are attributable to 
lifestyle factors such as smoking, alcohol 
consumption, diet, weight, and physical 
activity, and nearly 600 000 cancer cases in 
the UK could have been avoided in the past 
5 years if people had healthier lifestyles.1 
Prevention strategies are likely to require 
a combination of approaches that target 
the underlying determinants of cancer 
at both population and individual levels. 
With more than 300 million consultations 
taking place each year,2 general practice 
provides an ideal platform from which to 
deliver individual-level interventions. It is 
already the largest site of delivery for the 
NHS Health Check programme and brief 
interventions based in general practice 
have been shown to reduce smoking3,4 and 
alcohol consumption,5 as well as promoting 
physical activity 6,7 and weight loss.8,9 With the 
exception of smoking cessation, however, 
almost all of these interventions focus on 
cardiovascular disease (CVD); there is little 
discussion about cancer.
A number of risk tools are now available 
that predict an individual’s future risk of 
cancer. These include the Harvard Risk 
Tool,10,11 QCancer,12,13 and large numbers of 
disease-specific tools (for example, the Gail 
risk model for breast cancer).14 Each tool 
uses risk factors, such as age, sex, family 
history of cancer, and medical history, 
alongside lifestyle factors to estimate an 
individual’s risk of developing cancer over a 
defined time period, often 10 years. 
A number of theories of health behaviour 
change suggest that risk perception may 
be an important factor associated with 
preventive behaviours.15,16 Being able to 
estimate and communicate individual risk, 
and demonstrate the impact of lifestyle 
change on future risk of cancer, therefore, 
has the potential to motivate behaviour 
change. A recent systematic review of 
cancer risk assessment tools in primary 
care suggests their use has potentially 
beneficial effects on the accuracy of patient 
risk perception and knowledge, intentions 
to have cancer screening, and changes in 
diet and physical activity, without causing an 
increase in cancer-specific anxiety.17 
Unlike similar risk tools for other 
conditions (such as QRisk2,18 Predict CVD,19 
the Framingham risk score for CVD,20 the 
FRAX fracture risk assessment tool,21 and 
QFracture),22 these tools for cancer are 
not integrated into primary care computer 
systems or routinely used in practice. The 
aim of this study, therefore, was to explore 
health professionals’ views on the potential 
for incorporating into general practice 
personalised cancer risk information based 
on lifestyle factors to improve understanding 
of cancer prevention and promote behaviour 
change.
Research
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Background
It is estimated that approximately 40% of all 
cases of cancer are attributable to lifestyle 
factors. Providing people with personalised 
information about their future risk of cancer 
may help promote behaviour change.
Aim
To explore the views of health professionals 
on incorporating personalised cancer risk 
information, based on lifestyle factors, into 
general practice.
Design and setting
Qualitative study using data from six focus 
groups with a total of 24 general practice health 
professionals from the NHS Nene Clinical 
Commissioning Group in England. 
Method
The focus groups were guided by a schedule 
covering current provision of lifestyle advice 
relating to cancer and views on incorporating 
personalised cancer risk information. Data 
were audiotaped, transcribed verbatim, and 
then analysed using thematic analysis.
Results
Providing lifestyle advice was viewed as a core 
activity within general practice but the influence 
of lifestyle on cancer risk was rarely discussed. 
The word ‘cancer’ was seen as a potentially 
powerful motivator for lifestyle change but the 
fact that it could generate health anxiety was 
also recognised. Most focus group participants 
felt that a numerical risk estimate was more 
likely to influence behaviour than generic 
advice. All felt that general practice should 
provide this information, but there was a clear 
need for additional resources for it to be offered 
widely. 
Conclusion
Study participants were in support of providing 
personalised cancer risk information in general 
practice. The findings highlight a number of 
potential benefits and challenges that will 
inform the future development of interventions 
in general practice to promote behaviour 
change for cancer prevention. 
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METHOD
Design
A qualitative study was carried out, using 
data collected from focus groups with 
health professionals.
Participants and recruitment
GPs, GP registrars, practice nurses, student 
nurses, and clinical commissioners were 
recruited from practices within the NHS 
Nene Clinical Commissioning Group 
(CCG). Nene CCG plans and commissions 
healthcare services in the East Midlands 
in England on behalf of a population of 
approximately 650 000 and includes 69 GP 
surgeries. Four recruitment strategies were 
used: 
• GP surgeries across Nene CCG were 
approached and invited to take part in the 
study. If a surgery expressed an interest 
in taking part, all health professionals at 
that practice were individually emailed 
a letter of invitation and the study 
information leaflet; 
• all GPs within a local professional 
development group were individually 
emailed and invited to take part; 
• letters of invitation and the study 
information leaflet were emailed to all 
current GP registrars and student nurses 
through the Northampton GP training 
scheme coordinator and the University of 
Northampton nursing course portal; and 
• details of the study and the invitation to 
take part were circulated with the weekly 
newsletter to all Nene CCG members. 
Recruitment took place between 
November 2015 and February 2016, ending 
only when data saturation was achieved.
Data collection
Each focus group was led by two researchers 
and guided by a schedule (available from 
authors on request) to explore: 
• participants’ views on presenting 
personalised information about the 
risk of developing common cancers in 
general; and 
• future implementation. 
For those focus groups involving GPs 
and primary care teams, this included 
whether they felt that the provision of 
such information is within the scope of 
primary care and, if so, how this would 
be integrated. For the focus groups with 
clinical commissioners, the discussion 
focused mainly on funding and service 
provision. In all groups, participants were 
first asked how people in their practice 
currently get information about their 
future risk of disease and lifestyle advice 
in general, and about cancer specifically. 
They were then shown an example of a 
personalised risk estimate (Figure 1); this 
illustrated the 10-year risk of colon cancer 
for a hypothetical 65-year-old female now 
and if she made lifestyle changes. 
Analysis
Focus groups were audiotaped and 
transcribed verbatim, then analysed using 
thematic analysis with the aid of NVivo 
software (version 10). After reading and 
re-reading the transcripts, two researchers 
developed a coding frame. 
Once coding was completed by the same 
two researchers and any discrepancies 
resolved following discussion with a third 
researcher, a written summary of the data 
was created for each code using the ‘one 
sheet of paper’ method23 — this involves 
every section of data relevant to that code 
from all the focus groups being noted. This 
allowed identification of the key themes 
within the data and any outlying views. 
These themes were then explored in depth, 
looking for any patterns across different 
professional groups, sex, and years of 
experience. 
The data were analysed as they were 
collected in order to assess when data 
saturation was reached. This initial analysis 
was performed by four researchers (a 
UK GP, a health psychologist, and two 
non-clinical researchers experienced 
in qualitative health research), with the 
final interpretation agreed by all seven 
researchers.
RESULTS
A total of 24 general practice health 
professionals took part across six focus 
groups, with three to five participants per 
How this fits in
Approximately 40% of all cases of cancer 
are attributable to lifestyle factors. General 
practice interventions have been shown 
to be effective in lifestyle modification but 
have not routinely targeted cancer. In this 
study, primary care health professionals 
supported the provision of personalised 
cancer risk information and numerical 
risk estimates in general practice. 
They identified a number of potential 
benefits and challenges, and the findings 
can inform the future development of 
interventions to promote behaviour change 
for cancer prevention in general practice.
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group. Three groups were held in GP practices 
with GPs, nurses, and student nurses, two 
with GP registrars and primary care nurses 
within the University of Northampton, and 
one with clinical commissioners at Nene 
CCG’s offices. Participant characteristics 
are given in Table 1. Five key themes were 
identified from the data: 
• current lack of focus on the role of lifestyle 
factors in cancer; 
• the power of the word ‘cancer’;
• presentation of personalised cancer risk;
• facilitators and barriers to incorporating 
cancer risk information into general 
practice; and
• alternative settings.
Apart from the anticipated different 
perspective provided by the clinical 
commissioners around funding and 
service provision, there were no differences 
between the views of GPs and nurses, 
males and females, or those with different 
levels of experience. 
For context, job titles and years of 
experience of participants are given after 
quotations.
Lack of focus on the role of lifestyle 
factors in cancer 
Providing health promotion and lifestyle 
advice was viewed as a core activity in general 
practice. Most of this work was carried 
out by nurses via the NHS Health Check 
programme or in dedicated appointments 
initiated by patients or through GP referrals. 
It was unusual for GPs to have specific time 
for health promotion and they tended to fit 
it in during other appointments. Most of the 
advice given during those consultations was 
focused on CVD; although GPs recognised 
that many of the risk factors overlap with 
those for cancer, cancer was only raised 
opportunistically — and mostly in relation to 
smoking and lung cancer: 
‘I don’t think … I specifically address cancer 
risk in those consultations, it’s more 
opportunistic for me so like … if you do a 
smear [test], that kind of cancer risk crops 
up. But just general cancer risk, I think 
if I’m talking about risk with a patient it’s 
generally cardiovascular risk. I don’t think 
at the moment I really mention cancer 
unless it’s linked to smoking.’ (GP 5, focus 
group 4, 5–10 years) 
Those involved in commissioning were 
also not aware of any current services 
targeting cancer prevention:
‘I don’t think we do many or if any, you know, 
sort of cancer risk assessments or planning 
for cancer in that sense.’ (GP commissioner 
2, focus group 5, 5–10 years)
In addition, although all participants 
were familiar with, and regularly used, risk 
assessment tools for CVD, none was aware 
of any similar tools for cancer. 
The power of the word ‘cancer’
Several participants in each group 
mentioned the power of the word ‘cancer’, 
and there was a general view that people 
may make more lifestyle changes in 
response to risk of cancer than to risk of 
CVD because they perceive cancer to be 
more serious, or are more afraid of it:
‘I think this might be quite a positive in 
terms of changing their lifestyle because 
I think someone is more likely to change 
their lifestyle when presented with a cancer 
risk than when presented with a heart 
attack or a stroke risk, because I think heart 
Figure 1. Diagrammatic example of a personalised 
risk estimate providing the 10-year absolute risk 
of colon cancer for a hypothetical patient shown to 
focus group participants.
Table 1. Participants’ 
characteristics (n = 24)
Characteristic n
Sex 
 Male 10 
 Female 14
Profession 
 GP 11 
 GP clinical commissioner 3 
 Nurse 7 
 Clinical commissioner 3
Experience  
 In training 8 
 <5 years 4 
 5–10 years 5 
 >10 years 7
Your risk
31%
Your personal risk of developing bowel cancer
60%
50%
40%
30%
20%
10%
0%
Your lowest
possible risk
15%
What does your risk mean?
Your risk now: your risk of developing bowel cancer in your lifetime is about 31%. This means 
around 31 out of 100 women like you (31%) will develop bowel cancer. It does not mean you 
will definitely get cancer. It is just an estimate based on your risk factors, some of which you 
may be able to change. 
 
Your lowest possible risk: your risk if you followed all recommended advice would be about 15%. That 
means that around 15 out of 100 women like you (15%) would develop bowel cancer in your lifetime. 
What you can do to reduce your risk
You are already doing physical activity for at least 30 minutes a day and you are not smoking. 
Keep up your good work in these areas.
Further things that you could do to lower your risk include:
• lose weight to achieve a body mass index (BMI) of <27 kg/m2;
• eat three or more servings of vegetables a day;
• eat fewer than three servings of red meat (beef, lamb, or pork) a week; and
• drink fewer than one serving of alcohol a day.
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attack and a stroke most people recover, 
you know, but cancer I think people think 
it’s a lot more serious.’ (GP 4, focus group 4, 
>10 years)
‘I think certainly some people [would make 
lifestyle changes], purely out of the fact 
that some people are so fearful of the word 
‘cancer’, as soon as you mention it they 
probably want to do something. If you talk 
about the risk of getting dementia or the 
risk of getting heart disease in the future it 
doesn’t seem to strike them as much, but 
as soon as you mention the C word, they 
probably act a lot more, I think.’ (GP trainee 
2, focus group 3, in training)
This was particularly thought to be the 
case for younger people, for whom cancer 
was felt to be more relevant than CVD: 
‘I think cancer’s more, especially in the 
young … it’s something that they can relate 
to because they may know of someone with 
cancer, whereas cardiovascular disease I 
think they see as something [that] happens 
to older people and not something they 
need to worry about right now.’ (GP 2, focus 
group 1, <5 years) 
There was acknowledgement, however, 
of the challenges of trying to get people 
to change their behaviour; one participant 
likened it to ‘bang[ing] our heads against 
brick walls’ (GP trainee 2, Focus group 3, 
in training). The potential for discussions 
about cancer risk to be demotivating if 
patients perceived the risk to be high, and 
therefore unchangeable, and the possibility 
of generating health anxiety and reinforcing 
anxiety in those already concerned about 
their health were also raised across the 
focus groups:
‘… you want to make sure that the 
information you’re giving people is not 
only understandable but that it doesn’t 
completely alter them in a way that’s 
unhelpful, because you don’t want to induce 
health anxiety because that’s, you know, 
that doesn’t help us or them mostly.’ (GP 
trainee 3, focus group 3, in training)
‘It [the risk estimate] may be quite high 
and a bit demotivating if you think “well no 
matter what I do, you know, I’m going to get 
cancer”, which might be what some people 
take away from this.’ (GP 4, focus group 4, 
>10 years)
Several individuals, however, discussed 
how cardiovascular risk assessment and 
faecal occult blood testing had generated 
anxiety when they were first introduced, but 
people ‘just expect it now’ (student nurse 1, 
focus group 1, in training). Normalising 
cancer risk by making it part of routine care 
was, therefore, seen as an important way to 
reduce the potential for generating anxiety:
‘So if it was more of a routine type, you 
know, check, but for the younger age group 
or whatever, then that would normalise it, 
wouldn’t it? So perhaps the anxiety wouldn’t 
be as great.’ (Nurse 1, focus group 1, 
>10 years)
‘But it’s all about what people expect at the 
moment and what we’re doing so maybe 
not now, but maybe in 5 years, everyone will 
expect a letter about their cancer risk when 
they turn 30, like they expect their smear 
[test] letter. And if they know that’s coming, 
then it’s more acceptable isn’t it?’ (GP 2, 
focus group 1, <5 years) 
Presentation of personalised cancer risk
Many participants felt providing a 
personalised cancer risk would be more 
likely to influence behaviour than generic 
information:
‘I think a generic cancer message is less 
likely to hit home, or it’s less likely to 
influence an individual … I think people 
need to see the relevance to them … so 
personalising it makes it a bit more likely 
that they will absorb the information and do 
something about it.’ (GP 7, focus group 2, 
>10 years) 
Almost all also thought the risk should 
be presented as a numerical estimate. 
They felt that providing numbers makes 
the assessment ‘a more powerful tool’ 
(GP trainee 1, focus group 3, in training), 
with patients feeling ‘it’s more personalised 
or applicable to them’ (GP 2, focus group 1, 
<5 years).
Several participants felt numbers made 
it easier for patients to understand, and 
referred specifically to their experience of 
discussions around the risks of hormone 
replacement therapy (HRT) to illustrate this:
‘I found it really useful prescribing HRT 
using the table in the BNF [British National 
Formulary], which has actual numbers for 
risk of breast cancer and thromboembolism 
and, if you give the patient actual numbers 
they seem to respond to that better than 
just saying “you have an increased risk” … I 
think it’s easier for patients to understand.’ 
(GP 5, focus group 4, 5–10 years)
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There was much discussion in all 
groups about the relative advantages and 
disadvantages of presenting the risk of 
individual cancers, compared with presenting 
a combined risk for the most common 
cancers or those for which lifestyle factors 
have the biggest impact. All participants felt 
that there was a place for risk scores for 
individual cancers to be used with patients 
presenting with concerns about one or 
more cancers or wanting specific details. 
However, the general consensus was that a 
combined risk — perhaps with details of the 
top cancers contributing to that risk — might 
be better for general health promotion:
‘I think patients might want overall, but it’s a 
bit of a fluffy concept … if you just give them 
their overall cancer risk it’s hard for them 
to think about specifics. But if we’re really 
targeting it for health promotion, if we just 
did the overall cancer risk then actually it’s 
just about getting them to think about it, 
and that would get them to think about it …’ 
(GP 5, focus group 4, 5–10 years)
Some participants went further and felt 
that, as the lifestyle advice was similar to that 
for cancer and CVD prevention, separating 
them was potentially overcomplicating the 
message and more confusing — an overall 
health promotion message might be more 
effective.
‘… you’re at 31% risk of cancer … and by 
the way you’ve got a 15% chance of stroke, 
cardiovascular as well … so I think it needs 
to be seen as sort of a broader health.’ 
(Student nurse 2, focus group 6, in training)
Facilitators and barriers 
All groups felt that the NHS should be 
providing information about cancer risk, 
with the majority believing there was value 
in providing it face to face and that general 
practice was the most appropriate setting:
‘… we’re best placed to do it out of everyone, 
the best place to have that little bit [of] 
extra time, the face-to-face contact, and the 
opportunity to do it.’ (GP 5, focus group 4, 
5–10 years)
There was recognition among all 
participants that much of the advice they 
already provide is relevant to cancer, and 
so adding advice about cancer into practice 
would be relatively straightforward:
‘I think it’s just the overlap with 
cardiovascular disease, we’re doing a lot 
of it already so we probably do it quite well 
anyway.’ (GP 3, focus group 4, 5–10 years)
‘You wouldn’t be asking the nurses or the 
healthcare assistants to ask [for] any more 
information than they already do — they 
already ask their weight and their diet and 
their family history and their alcohol — and 
it would be a springboard for the rest of 
their consult, so it would be kind of a useful, 
you know, it would cover a few bases.’ (GP 
trainee 3, focus group 3, in training)
As with current lifestyle services, it was 
felt that most advice would come from 
nurses and healthcare assistants, with 
patients at high risk referred to GPs for 
a further discussion. The challenge was 
finding the right time and accessing the 
right group of people: 
‘You have to have appropriate risk provided 
at appropriate times and that’s the key isn’t 
it really, so people have to be willing to hear 
the message.’ (GP commissioner 1, focus 
group 5, 5–10 years)
‘People who worry about their health 
obsessively are the ones we see more 
and they’re already worried about having 
cancer and probably already doing most 
things right … whereas you want to get the 
message out to the people who are not in 
the doctor’s surgery.’ (GP 3, focus group 4, 
5–10 years) 
Across the groups, four main options to 
provide information about cancer risk within 
general practice were identified: 
• opportunistically; 
• within NHS Health Checks; 
• within existing cancer screening 
programmes; or 
• within new-patient health appointments.
Most participants felt happy to discuss 
cancer risk opportunistically, but there 
was a general consensus that, although 
providing the information to older patients 
might be helpful, the focus should be on 
targeting younger people in their 20s and 
30s for whom any lifestyle changes would 
have the greatest impact. In addition, focus 
group members felt that offering cancer 
risk estimates to people who attend general 
practice is likely to identify mostly older 
people and those who are already health 
conscious. A small number of GPs were 
also unsure how comfortable they would 
feel introducing the subject of cancer if 
it had not already come up in some way 
during the consultation: 
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‘I’d be happy using this tool — there’s a lot 
of positive things about it — but I don’t know 
how happy I’d be using it just cold, in a sort 
of health promotion-type setting without 
giving the patient some kind of inkling that 
it might be coming.’ (GP 4, focus group 4, 
>10 years)
Adding cancer risk information to NHS 
Health Checks or sending information 
out with letters about national screening 
programmes was felt to make sense and 
to fit nicely:
‘Yeah, [fitting it into NHS Health Checks] 
would make perfect sense because they’ve 
got all the information anyway because 
they’re doing all the risk, they’re doing all 
the lifestyle stuff anyway aren’t they?’ (GP 6, 
focus group 4, 5–10 years)
However, it was recognised that the 
NHS Health Check programme was 
targeted at older people and that screening 
programmes, such as cervical screening, 
focus on women more than men. As a 
result, appointments for new patients were 
felt to be the least biased:
‘I think women do engage with health 
concerns more than men. That’s why if you 
had an avenue to collect people in a way 
that’s not centred around this, but you could 
pick it up during that contact, so like the 
health questionnaires or a new patient, you 
know — everybody’s got to have a GP so you 
could incorporate it in there quite nicely and 
that way you wouldn’t get a population bias.’ 
(GP trainee 3, focus group 3, In training)
Whichever route was chosen, however, 
there was a clear need for additional 
resources if it was going to be offered 
widely. Participants mentioned the need for 
additional funding and time:
‘So it would have to be … funded as an 
enhanced service if that was something 
that was going to be delivered in primary 
care in its own right, unless it was just 
an optional thing you say like many other 
things we know, you know, we have training 
on.’ (GP 6, focus group 4, 5–10 years)
‘I think anything would have to be funded 
wouldn’t it? Because we’re kind of really 
stretched as it is.’ (Nurse 2, focus group 1, 
>10 years) 
‘… if someone came in and said “Oh I’m 
worried about my cancer risk, what can 
you tell me?” and then you thought “Oh 
I’ve seen that risk score, I’ll get that up 
and do it” but that would be a very rare 
scenario in primary care that someone 
would actually come in specifically asking 
about that one issue. They’ll generally come 
in about something else … I just think 
realistically it wouldn’t get done unless it 
was sort of dedicated time.’ (GP 6, Focus 
group 4, 5–10 years) 
Referral pathways were thought to be 
needed to support lifestyle change:
‘And the other thing would depend on what 
avenues we had open to us to follow up 
… I mean I see quite a lot of patients now 
who are worried about family history and 
we end up referring to clinical genetics 
with the family history questionnaires, and 
that’s fine because you know you’ve got 
something to offer them … whereas with 
this we haven’t got a pathway.’ (GP 6, focus 
group 4, 5–10 years)
 
Participants also saw the importance 
of this being integrated into the computer 
system: 
‘… if you want to get that out to every 
practice and every GP, then it needs to be 
integrated.’ (Clinical commissioner 1, focus 
group 5, <5 years)
‘… the computer system needs to be able 
to extract everything that it wants without 
having to type in extra information at the 
time, and you need to be able to click on 
a button and it just instantly spits out the 
whole thing ready for you, you know. You 
don’t want to be having to go and re-enter, 
sort of, how many bits of fruit they ate in 
the last week before it’ll produce its thing.’ 
(GP 8, focus group 2, >10 years)
The point that screening resources might 
also need to improve was also raised:
‘I think you may have increased demand 
again from patients in terms of saying, 
“Well my risk is this high, I want this test 
and I want this screening, you know, I 
want to be screened.” So as long as that’s 
accommodated for as well, and that’s 
thought about.” (GP trainee 1, focus group 3, 
in training)
It was also recognised that training would 
be needed. One nurse (Nurse 2, focus group 
1, >10 years) commented that ‘… everybody 
needs training’, whereas a GP noted: 
‘Anyone could give you advice if they 
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were trained to, trained in the risk tool 
and understood it.’ (GP 4, focus group 4, 
>10 years)
Additional barriers mentioned by 
those involved in commissioning services 
included the continued reorganisation of 
services over the last 10 years, movement 
of public health out of health care into the 
local authorities, and the current instability 
of funding:
‘Public health was part of the health care, 
not part of the local authority, so you 
could actually agree pathways and can 
work together to do that, but now they’re 
within local authority and the politics of 
local authority is completely different, you 
know, it’s a different agenda.’ (Clinical 
commissioner 3, focus group 5, <5 years) 
‘The continued reorganisation that’s gone 
on over the last 10 or so years has meant 
that smoking cessation has migrated from 
one community of providers to another 
… if it’s constantly changing so that even 
the GP isn’t sure where the service is 
being provided, then that’s probably not so 
helpful.’ (GP commissioner 1, focus group 
5, 5–10 years)
Alternative settings 
In addition to providing cancer risk 
information in general practice, all the 
groups felt it was important to increase 
the accessibility of the information, so 
people did not have to visit their GP, and to 
make use of technology to engage younger 
people. Suggestions included: 
• providing face-to-face consultations in 
pharmacies, supermarkets, and schools; 
• allowing individuals to assess their own 
risk via websites, mobile applications, 
or ‘cancer booths’, potentially supported 
by videos to explain how to interpret the 
results; and 
• offering risk assessment by post. 
As one participant said:
‘You could get a booth couldn’t you, a booth, 
like a photo booth and you plug in all your 
things and then it goes “your cancer risk 
is 30%”.’ (GP trainee 3, focus group 3, in 
training)
The potential for increasing anxiety was 
again raised in these discussions, however, 
with recognition that there was a balance 
between accessibility and interpretation:
‘… the only problem with making it too 
accessible is the interpretation. If a patient 
sees that and goes “Oh my God, I’m going 
to die” … actually you’re there to interpret 
the information in the surgery.’ (GP 3, focus 
group 4, 5–10 years)
DISCUSSION
Summary
This study showed that, among the UK 
health professionals who took part, there 
is support for providing personalised 
cancer risk information in general practice. 
The findings highlighted a number of 
potential benefits and challenges, which 
could inform the future development of 
interventions to promote behaviour change 
for cancer prevention in general practice. 
These include: 
• the power of the word ‘cancer’ to motivate 
lifestyle change, but recognition of its 
potential to also generate health anxiety; 
• the preference for risk to be presented as 
a numerical estimate for both an overall 
cancer risk and individual cancers; 
• the challenge of finding the right time and 
place to provide the risk information, and 
accessing those most likely to benefit; 
and 
• the need for additional resources, 
including funding, time, referral pathways, 
integration within the electronic health 
record, and training.
Strengths and limitations
To the authors’ knowledge this is the 
first study detailing the views of health 
professionals on incorporating personalised 
cancer risk information into general 
practice in the UK. A diverse sample of 
health professionals was recruited in terms 
of sex, profession, and level of experience. 
The use of semi-structured, qualitative data 
collection allowed their views on key areas 
to be explored while areas they felt were 
important could be raised. 
There are some limitations that should 
be noted, however. The sample size was 
small and all participants were recruited 
from one region in England, which limits 
the generalisability of the findings. The 
individuals and practices that took part 
were also those that chose to give up their 
time to participate, so it is possible they may 
be more interested in the subject and more 
supportive of using personalised cancer 
risk information than health professionals 
in the wider community.
Comparison with existing literature
The findings from this study are consistent 
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with those from similar studies undertaken 
in the US,24–27 Australia,28 and France.29 As 
in those studies, there was not only support 
for providing cancer risk information in 
practice, but also recognition that trying 
to get people to change their behaviour 
is difficult,26,27 and there is a need for 
additional funding,28 time,24–28 integration 
into the current electronic health record,29 
and training24,29 for implementation to be 
successful. 
One of the biggest challenges raised 
was finding the best time and place for the 
risk assessment. Participants in the study 
reported here felt that general practice 
was the most appropriate setting and that, 
ideally, the risk should be delivered face 
to face. This was also the view of breast 
surgeons and primary care physicians in 
the study in Australia.28 Other studies have, 
however, demonstrated the feasibility of 
providing the information via the internet,30 
as a leaflet,31 or incorporated within 
screening programmes.32 
The findings that almost all participants 
in this study thought the risk should be 
presented as a numerical estimate and 
that personalised messages were more 
likely to influence behaviour than messages 
directed towards the entire population is 
also consistent with previous reports.26,33 
Implications for research and practice 
Much of the lifestyle advice already 
provided in relation to CVD is relevant to 
cancer, so adding advice about cancer into 
practice could be relatively straightforward. 
However, this study highlighted a number 
of factors that should be considered when 
incorporating cancer risk information into 
general practice. The first is the format and 
content of the risk information. This study 
suggests addressing issues by:
• presenting a numerical estimate, with 
details of how that would be reduced 
in response to lifestyle changes for a 
combined cancer risk and the most 
common individual cancers; 
• providing information face to face in 
general practice; and 
• targeting younger people and those most 
likely to benefit from lifestyle changes, 
perhaps at new-patient health checks. 
Health professionals, however, often have 
difficulty interpreting and communicating 
risk scores to patients.34,35 In addition, 
previous studies on presenting cancer 
risk to individuals have highlighted the 
difficulties patients have understanding the 
concept of risk.36,37 It is also unlikely that one 
strategy will suit all and so further research 
is needed with both health professionals 
and patients to identify the optimal method 
of information provision. 
The second is the need to provide 
additional resources, particularly time, 
funding, and referral pathways. At a time 
when demand for health care is increasing 
and funding decreasing, these are likely 
to be the greatest barriers. The ongoing 
reorganisation of the NHS and movement 
of public health away from health care 
into the remit of local authorities will also 
make introducing new prevention services 
more challenging. Any future initiatives will 
require the support not only of GPs and 
clinical commissioners, but also of public-
health and third-sector organisations. 
Providing risk information via the internet, 
mobile applications, or written leaflets 
instead may be more cost-effective but 
this must be balanced against the risk of 
generating anxiety. 
Finally, before personalised cancer risk 
information is introduced in any format, 
there must be some assurance that health 
professionals will not be causing harm. 
A recent systematic review of cancer risk 
assessment tools in primary care suggests 
their use could have beneficial effects 
without causing an increase in cancer-
specific anxiety;17 however, this hypothesis 
was based on only three trials so further 
research is needed to quantify the potential 
benefits and harms of providing cancer risk 
information in routine general practice.
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